Established in 2000, Flagship Pioneering (previously known as Flagship Ventures) is a venture capital firm founded by Noubar Afeyan and Edwin Kania. The firm primarily operates from Cambridge, Massachusetts although it also has an office in Ann Arbor, Michigan. The firm is currently managing a portfolio containing 37 companies and has sold off its shares in 121 companies. The firm’s most recent investment occurred in December 2018 for Indigo Agriculture, a biotechnology company specializing in plant microbiome agricultural services.
Flagship Pioneering focuses on funding startups that operate in the United States, especially in the Midwest region. The firm prefers to fund companies in the therapeutics, health technologies, life science, sustainability and clean technology business industries. It provides financing for companies at various stages of development, from incubation to growth stage. With its latest funding round raised in September 2017, the firm has managed to collect a total fund of $2.8 billion. During the September 2017 funding round, the firm amassed a total of $618 million in capital.
Flagship Pioneering launches new agtech company to manage insect populations.
A company developing antibody-based biological medicines for kidney diseases and other chronic diseases. Visterra was acquired by Otsuka Pharmaceutical in 2018.
Codiak Biosciences is a biotechnology company developing exosome therapeutics.
Editas Medicine is a genome editing company founded in 2013 that is using CRISPR technology to treat patients with genetically defined diseases.
Rubius Therapeutics is a biotechnology company using stem cells to develop red blood cell cellular therapies.
T2 Biosystems is a Lexington, Massachusetts-based company developing diagnostic products targeting sepsis and in vitro diagnostic products intended to target sepsis, hemostasis, bacteria, and lyme disease founded in 2006 by Robin Toft.
Indigo is an agricultural technology company utilizing natural microbiology and digital technologies to improve farmers' profitability, environmental sustainability and consumer health.
Foghorn Therapeutics is a Cambridge, Massachusetts-based company developing therapies based on a system directing which genes cells express.
A company focused on mapping and controlling the genes to treat diseases
Intio is a Broomfield, Colorado-based diagnostic tools company focused on diagnostics for oncology.
Tangent Medical Technologies is an Ann Arbor, Michigan-based healthcare company.
KSQ Therapeutics is a Cambridge, Massachusetts-based company.
Cygnal Therapeutics is a Cambridge, Massachusetts-based company.
Associated investment funds
Adam J Koch
Chief Financial Officer
Chief Operating Officer
Jason Patrick Schrum
Documentaries, videos and podcasts